We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

145 hedge funds and large institutions have $284M invested in BioDelivery Sciences International, Inc. in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

432% more call options, than puts

Call options by funds: $851K | Put options by funds: $160K

29% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 41

13% more capital invested

Capital invested by funds: $252M → $284M (+$31.6M)

4% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 23

1% less funds holding

Funds holding: 147145 (-2)

Holders
145
Holders Change
-2
Holders Change %
-1.36%
% of All Funds
2.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
53
Reduced
41
Closed
23
Calls
$851K
Puts
$160K
Net Calls
+$691K
Net Calls Change
+$345K
Name Holding Trade Value Shares
Change
Change in
Stake
DM
1
Deerfield Management
New York
$40M +$7.3M +1,894,250 +25%
BlackRock
2
BlackRock
New York
$34.5M +$2.68M +696,022 +9%
NCM
3
Nantahala Capital Management
Connecticut
$21.5M +$222K +57,716 +1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$20.2M +$776K +201,389 +4%
WA
5
Wasatch Advisors
Utah
$19.3M +$9.73M +2,524,858 +123%
SFM
6
Systematic Financial Management
New Jersey
$15.1M +$727K +188,551 +6%
RCMNY
7
Rubric Capital Management (New York)
New York
$14.8M -$1.86M -483,876 -12%
State Street
8
State Street
Massachusetts
$8.43M +$76K +19,710 +1%
N
9
Nuveen
North Carolina
$7.81M +$263K +68,306 +4%
Goldman Sachs
10
Goldman Sachs
New York
$7.19M +$2.08M +539,544 +46%
HP
11
HealthInvest Partners
Sweden
$6.62M +$6.07M +1,575,000 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$5.72M +$137K +35,516 +3%
SAM
13
Silvercrest Asset Management
New York
$4.93M +$824K +213,881 +22%
Northern Trust
14
Northern Trust
Illinois
$4.48M -$98.8K -25,627 -2%
William Blair & Company
15
William Blair & Company
Illinois
$4.28M +$172K +44,644 +5%
UBS Group
16
UBS Group
Switzerland
$4.14M +$3.76M +975,846 +9,163%
JAM
17
Jupiter Asset Management
United Kingdom
$3.84M
Los Angeles Capital Management
18
Los Angeles Capital Management
California
$3.5M +$174K +45,043 +6%
1CM
19
1492 Capital Management
Wisconsin
$3.32M -$52.5K -13,627 -2%
Charles Schwab
20
Charles Schwab
California
$2.96M +$84.2K +21,848 +3%
Russell Investments Group
21
Russell Investments Group
United Kingdom
$2.83M +$760K +197,200 +41%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$2.69M -$1.75M -454,300 -42%
MF
23
Magnetar Financial
Illinois
$2M +$98.6K +25,584 +6%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$2M +$126K +32,645 +7%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$1.82M +$358K +92,928 +27%

BDSI Hedge Fund Activity: Q4 2020 in Review

145 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2020, worth a combined $284M — up 13% from $252M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of BDSI and 22 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 53 added.

The largest buyer was Wasatch Advisors, adding an estimated $9.73M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $7.27M sold.

  • 145 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2020, down from 147 in Q3 2020.
  • Funds reported $284M of BioDelivery Sciences International, Inc. stock for Q4 2020, up 13% quarter-over-quarter.
  • 22 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2020 and 23 closed out, a net change of -1 holder.
  • The largest BioDelivery Sciences International, Inc. buyer in Q4 2020 was Wasatch Advisors, an estimated $9.73M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q4 2020 was Adage Capital Partners, an estimated $7.27M sold.

Based on aggregated 13F filings for Q4 2020.